|
The device was not returned for analysis.Production record and corrective and preventative actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a query of the complaint handling database for the reported lot revealed there is no indication of a lot specific issue.It was reported that the rx graftmaster was used past the expiration date.A review of the rx graftmaster label attached to the lot history record for this lot was conducted indicating a manufacturing date of 24-october-2023 with an expiration date (use by date) of 30-september-2025.The product was used after expiration as it was reported the procedure occurred on (b)(6) 2025.The expiration date of the product is important for sterility, efficacy, and performance of the device.It should be noted that the graftmaster instructions for use (ifu) states: note the product ¿use by¿ (expiration) date specified on the package.In addition, it was reported that the procedure was to treat a pseudoaneurysm in the right coronary artery.It should be noted that the graftmaster ifu states: the graftmaster rx is indicated for use in the treatment of free perforations, defined as free contrast extravasation into the pericardium, in native coronary vessels or saphenous vein bypass grafts = 2.75 mm in diameter.The effectiveness of this device for this use has not been demonstrated.Long-term outcome for this permanent implant is unknown at present.The investigation determined the reported device expiration issue appears to be related to the use error.There is no indication of a product quality issue with respect to manufacture, design, or labeling.H6 medical device problem code: 1494 - indication for use, 2017 - use after expiration.
|